Pimodivir - CAS:1629869-44-8 - CAS号查询_生物试剂_化学试剂_分析试剂

中文名称:	Pimodivir
英文名称:	Pimodivir
别名:	VX-787
CAS No:	1629869-44-8	分子式:	C₂₀H₁₉F₂N₅O₂	分子量:	399.39
CAS No:	1629869-44-8
分子式:	C₂₀H₁₉F₂N₅O₂
分子量:	399.39

安全技术说明书(PDF) MSDS(PDF) 点击下载产品说明书(PDF)

P10667 Pimodivir ≥98% (psaitong)

相关产品

包装规格：

5mg 10mg 25mg 100mg in glass bottle

溶解性：

溶于DMSO（100 mg/mL 超声)

产品描述：

基本信息

产品编号：P10667
产品名称：Pimodivir
CAS:	1629869-44-8	储存条件	粉末	-20℃	四年

分子式：	C20H19F2N5O2		溶于液体	-80℃	六个月
分子量	399.39			-20℃	一个月
化学名：	(2S,3S)-3-((5-fluoro-2-(5-fluoro-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-4-yl)amino)bicyclo[2.2.2]octane-2-carboxylic acid
Solubility (25°C)	体外	DMSO	100mg/mL (250.38mM; Need ultrasonic)
		Ethanol
		Water
	体内	现配现用
＜1mg/ml表示微溶或不溶。
普西唐提供的所有化合物浓度为内部测试所得，实际溶液度可能与公布值有所偏差，属于正常的批间细微差异现象。
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；⼀旦配成溶液，请分装保存，避免反复冻融造成的产品失效。

制备储备液

浓度溶液体积质量	1mg	5mg	10mg
1mM	2.5038mL	12.5191mL	25.0382mL
5mM	0.5008mL	2.5038mL	5.0076mL
10mM	0.2504mL	1.2519mL	2.5038mL

生物活性

产品描述	一种可口服的甲型流感病毒聚合酶抑制剂，通过抑制PB2亚基起作用。
靶点/IC₅₀	Influenza Virus
体外研究	Pimodivir rescues macrophages from virus-mediated death at non-cytotoxic concentrations 24hpi. The EC50 value for Pimodivir are 8 and 12nM for A(H1N1) and A(H3N2) strains, respectively, whereas the CC50 values are >1μM, giving selectivity indexes (SI) > 125 and > 83 for A(H1N1) and A(H3N2) strains, respectively. Pimodivir significantly attenuates the transcription of viral M1 RNA in macrophages, which are infected with A(H1N1) or A(H3N2) strains for 8 h. Pimodivir inhibits the transcription of viral but not cellular genes. Pimodivir allows some activation of IAV-mediated expression of several cellular genes, which are involved in tryptophan and nucleotide metabolism. Pimodivir possesses excellent anti-IAV but not immuno/metabolo-modulating effect. Pimodivir (VX-787) is very potent against influenza A strains, including pandemic 2009 H1N1 and avian H5N1. Pimodivir (VX-787) shows potent activity against all influenza A virus strains tested, with an EC 50 range of 0.13 to 3.2nM. Pimodivir-selected PB2 variant viruses maintain susceptibility to neuraminidase inhibitors in vitro.
体内研究	Pimodivir (2, 6, and 20mg/kg/day, p.o.) and GS 4071 (20mg/kg/day) completely prevent death in the H1N1pdm virus infection in mice. Pimodivir (20mg/kg/day) is more effective than GS 4071 (20mg/kg/day) in improving body weight and reducing the severity of lung infection. Moreover, Pimodivir (VX-787) shows 100% survival in a +48 h delay to treatment mouse influenza model at 10, 3 and 1mpk (BID × 10 days) whereas the SOC, GS 4071, provide no survival benefit in this model at 10mpk. Pimodivir (VX-787; 1, 3, or 10mg/kg, bid) provided complete survival, with a dose-dependent reduction in BW loss of the mice.

推荐实验方法(仅供参考)

细胞实验:
Cell Assay	The compound cytotoxicity and efficacy testing is performed in 96-well plates with macrophages at 95% confluence. The compounds are added to the medium, and 30 min later, the cells are infected with virus or non-infected. The cell viability is analyzed with the Cell Titer Glo assay at 24hpi. The luminescence is read with a PHERAstar FS plate reader

动物实验:

Animal Administration

The mice are anesthetized, and the animals are infected intranasally with a 90-μL suspension of influenza virus. The virus challenge is approximately four 50% mouse lethal infectious doses. Treatments are given twice a day (at 12 h intervals) for 10 days starting 2 h before virus challenge. Parameters for assessing the infection are survival, mean day of death, body weight changes, and lung infection parameters (hemorrhage score, weight, and virus titer). Animals are weighed individually every other day through day 21 of the infection. Initially, there are 15 mice per group treated with compound and 25 placebos. Five mice in each group are subsequently sacrificed for determination of lung infection parameters. A larger number of placebos are used than compound-treated mice to achieve greater statistical power, especially if some animals in that group survive the infection. One mouse that dies during the treatment period is presumed to have died from treatment trauma because its death occurs well before other mice die from influenza. It is excluded from the total counts. Animals that die during infection are accounted for in the tabular data.

保存条件：

-20℃

UN码：

HazardClass：

危害声明：

安全说明：

搜索质检报告(COA)

参考文献 & 客户发表文献

本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系，公式为：
质量 (g) = 浓度 (mol/L) x 体积 (L) x 分子量 (g/mol)

摩尔浓度计算公式

质量 =

浓度 *

体积 *

分子量

*选择对应的单位 *空出希望得到的变量，填写另外两个变量

用本工具协助配置特定浓度的溶液，使用的计算公式为：
开始浓度 x 开始体积 = 最终浓度 x 最终体积

稀释公式

稀释公式一般简略地表示为：C1V1 = C2V2 ( 输入输出 )

* = *

连续稀释计算器方程

连续稀释
初始浓度:
稀释倍数:

计算结果

C1=C0/X	C1:	LOG(C1):
C2=C1/X	C2:	LOG(C2):
C3=C2/X	C3:	LOG(C3):
C4=C3/X	C4:	LOG(C4):
C5=C4/X	C5:	LOG(C5):
C6=C5/X	C6:	LOG(C6):
C7=C6/X	C7:	LOG(C7):
C8=C7/X	C8:	LOG(C8):

摩尔浓度计算公式

稀释公式

连续稀释计算器方程

连续稀释

计算结果